StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
323
This month
2
This year
28
Publishing Date
2024 - 03 - 06
3
2024 - 02 - 27
3
2024 - 02 - 26
3
2023 - 12 - 08
2
2023 - 11 - 30
2
2023 - 11 - 07
3
2023 - 11 - 02
2
2023 - 11 - 01
3
2023 - 10 - 17
3
2023 - 10 - 16
4
2023 - 09 - 20
2
2023 - 09 - 19
2
2023 - 08 - 01
2
2023 - 07 - 03
2
2023 - 05 - 30
2
2023 - 05 - 08
2
2023 - 05 - 01
2
2023 - 04 - 17
3
2023 - 03 - 07
2
2023 - 01 - 31
2
2022 - 12 - 13
2
2022 - 10 - 12
2
2022 - 08 - 30
2
2022 - 08 - 26
2
2022 - 08 - 23
2
2022 - 08 - 12
2
2022 - 08 - 08
2
2022 - 04 - 27
2
2022 - 04 - 26
2
2022 - 03 - 11
2
2022 - 03 - 01
2
2022 - 02 - 08
2
2022 - 02 - 07
2
2022 - 01 - 24
2
2021 - 12 - 20
2
2021 - 12 - 06
2
2021 - 12 - 03
3
2021 - 12 - 01
2
2021 - 11 - 12
2
2021 - 10 - 07
2
2021 - 09 - 20
2
2021 - 09 - 16
3
2021 - 09 - 13
3
2021 - 08 - 27
2
2021 - 08 - 05
2
2021 - 08 - 03
2
2021 - 07 - 30
2
2021 - 07 - 26
2
2021 - 07 - 08
2
2021 - 07 - 07
2
2021 - 06 - 23
3
2021 - 06 - 11
2
2021 - 06 - 01
2
2021 - 05 - 28
2
2021 - 05 - 21
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 12
2
2021 - 04 - 08
2
2021 - 01 - 11
2
Sector
Commercial services
1
Communications
2
Finance
5
Health technology
323
Manufacturing
1
Mining, quarrying, and oil and gas extraction
1
N/a
117
Process industries
1
Professional, scientific, and technical services
1
Technology services
1
Tags
Alliances
9
Antibody
5
Application
10
Approval
24
Asco
5
Asia
7
Association
6
Biocanada
9
Biotech-bay
15
Biotech-beach
6
Biotechnology
17
Brukinsa
17
Cancer
58
China
19
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
11
Collaboration
14
Conference
22
Dkn-01
6
Drug
5
Earnings
16
Europe
5
Events
22
Fda
16
Financial
16
Financial results
12
Genetown
15
Global
6
Health
5
Her2
5
Leap
13
Leukemia
11
License
10
Lumakras
12
Lung
6
Lung cancer
10
Meeting
10
N/a
131
Offering
6
People
8
Pharmaceutical
6
Pharmaceuticals
10
Phase 2
8
Phase 3
8
Pipeline
7
Plus
6
Positive
19
Product-news
9
Regulatory
8
Report
9
Research
23
Results
50
Study
9
Therapeutics
31
Therapy
8
Topline
8
Treatment
16
Trial
23
Update
6
Year
8
Entities
Abbvie inc.
11
Adaptimmune therapeutics plc
2
Adc therapeutics sa
5
Agios pharmaceuticals, inc.
10
Alnylam pharmaceuticals, inc.
10
Amgen inc.
117
Assembly biosciences, inc.
1
Astellas pharma inc
1
Astrazeneca plc
2
Atlas lithium corp
1
Atreca, inc.
1
Aveo pharmaceuticals, inc.
10
Beigene, ltd.
323
Bio-techne corp
1
Biogen inc.
1
Blueprint medicines corporation
10
Brazil minerals, inc.
1
Bristol-myers squibb company
12
Chemocentryx, inc.
50
Clearside biomedical, inc.
1
Clovis oncology, inc.
10
Codexis, inc.
1
Cytomx therapeutics, inc.
1
Eli lilly and company
19
Epizyme, inc.
10
Exact sciences corporation
1
Exelixis, inc.
10
Futu holdings limited
1
Gilead sciences, inc.
1
Horizon therapeutics public limited company
1
Hutchison china meditech limited
7
Illumina, inc.
10
Incyte corporation
12
Jazz pharmaceuticals plc
12
Johnson & johnson
3
Karuna therapeutics, inc.
2
Karyopharm therapeutics inc.
11
Leap therapeutics, inc.
35
Legend biotech corporation
1
Lithium corp
1
Mei pharma, inc.
1
Molecular templates, inc.
1
Morgan stanley
5
Nanostring technologies, inc.
1
Nektar therapeutics
1
Novartis ag
7
Orange
2
Pfizer, inc.
10
Protara therapeutics, inc.
2
Regeneron pharmaceuticals, inc.
15
Rigel pharmaceuticals, inc.
10
Sanofi
18
Springworks therapeutics, inc.
4
Ultragenyx pharmaceutical inc.
2
Verastem, inc.
10
Vor biopharma inc
2
Xencor, inc.
6
Y-mabs therapeutics, inc.
10
Zealand pharma a/s
2
Zymeworks inc.
54
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
323
Nyse
87
Crawled Date
2024 - 03 - 06
3
2024 - 02 - 27
3
2024 - 02 - 26
3
2023 - 11 - 30
3
2023 - 11 - 07
3
2023 - 11 - 02
2
2023 - 11 - 01
3
2023 - 10 - 17
4
2023 - 10 - 16
3
2023 - 09 - 20
2
2023 - 09 - 19
2
2023 - 08 - 01
2
2023 - 07 - 03
2
2023 - 05 - 30
2
2023 - 05 - 08
2
2023 - 05 - 01
2
2023 - 04 - 17
3
2023 - 03 - 08
2
2023 - 01 - 31
2
2022 - 12 - 14
2
2022 - 11 - 07
2
2022 - 10 - 12
2
2022 - 09 - 12
2
2022 - 08 - 30
2
2022 - 08 - 26
2
2022 - 08 - 23
2
2022 - 08 - 12
2
2022 - 08 - 08
2
2022 - 04 - 27
2
2022 - 04 - 26
2
2022 - 03 - 11
2
2022 - 03 - 01
2
2022 - 02 - 08
3
2022 - 01 - 24
2
2022 - 01 - 19
2
2021 - 12 - 20
2
2021 - 12 - 06
2
2021 - 12 - 03
3
2021 - 12 - 01
2
2021 - 11 - 12
2
2021 - 10 - 07
2
2021 - 09 - 20
2
2021 - 09 - 16
3
2021 - 09 - 13
3
2021 - 08 - 27
2
2021 - 08 - 05
2
2021 - 08 - 03
2
2021 - 07 - 26
2
2021 - 07 - 08
2
2021 - 07 - 07
2
2021 - 06 - 23
3
2021 - 06 - 11
2
2021 - 06 - 01
2
2021 - 05 - 28
2
2021 - 05 - 21
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 12
2
2021 - 04 - 08
2
2021 - 01 - 11
2
Crawled Time
00:00
10
00:20
1
01:00
6
05:00
3
06:00
3
07:00
5
08:00
6
09:00
10
10:00
8
11:00
21
12:00
50
12:15
1
12:20
9
12:30
6
12:39
1
13:00
25
13:15
2
13:20
4
13:30
5
13:50
1
14:00
20
14:15
2
14:20
3
14:30
3
15:00
11
15:15
1
15:20
1
15:30
2
16:00
8
16:20
6
17:00
6
17:37
1
18:00
4
18:04
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
8
20:00
15
20:20
2
20:59
1
21:00
17
22:00
13
22:01
1
23:00
14
Source
feed.businesswire.com
2
investor.assemblybio.com
1
www.biospace.com
192
www.fda.gov
10
www.globenewswire.com
44
www.hutch-med.com
1
www.prnewswire.com
73
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
BGNE
save search
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
Published:
2024-04-11
(Crawled : 10:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-2.85%
|
O:
0.77%
H:
2.61%
C:
1.96%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-13.62%
|
O:
-1.55%
H:
0.89%
C:
-1.01%
first
conference
report
financial
results
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Published:
2024-04-08
(Crawled : 10:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-8.57%
|
O:
0.0%
H:
1.76%
C:
-0.62%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-13.8%
|
O:
-0.94%
H:
1.12%
C:
0.61%
association
cancer
research
preclinical
for
meeting
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
Published:
2024-03-28
(Crawled : 10:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-14.08%
|
O:
0.49%
H:
2.13%
C:
1.64%
SNDX
|
$20.82
1.61%
1.59%
850K
|
Health Technology
|
-9.84%
|
O:
0.48%
H:
4.36%
C:
2.67%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-16.48%
|
O:
1.24%
H:
0.24%
C:
-0.39%
Zymeworks Announces Participation in Upcoming April 2024 Investor Conferences
Published:
2024-03-27
(Crawled : 11:00)
- biospace.com/
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-15.47%
|
O:
0.38%
H:
0.67%
C:
-2.0%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-15.79%
|
O:
-0.49%
H:
1.83%
C:
1.33%
Zymeworks Announces Participation in Upcoming Investor Conferences
Published:
2024-03-27
(Crawled : 10:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-15.47%
|
O:
0.38%
H:
0.67%
C:
-2.0%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-15.79%
|
O:
-0.49%
H:
1.83%
C:
1.33%
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation
Published:
2024-03-13
(Crawled : 13:30)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-20.9%
|
O:
10.52%
H:
2.11%
C:
-2.49%
brukinsa
first
collaboration
max
leukemia
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published:
2024-03-09
(Crawled : 20:20)
- prnewswire.com
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
CCXI
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
otezla
research
BeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published:
2024-03-07
(Crawled : 23:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-18.81%
|
O:
-0.93%
H:
3.2%
C:
2.66%
fda
brukinsa
approval
treatment
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-06
(Crawled : 21:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-27.64%
|
O:
-6.93%
H:
9.65%
C:
0.51%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-6.19%
|
O:
-0.12%
H:
0.41%
C:
-0.58%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-18.81%
|
O:
-0.93%
H:
3.2%
C:
2.66%
year
financial
results
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Published:
2024-03-06
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-18.81%
|
O:
-0.93%
H:
3.2%
C:
2.66%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.77%
|
O:
-0.1%
H:
0.18%
C:
-1.25%
BeiGene to Present Clinical and Preclinical Data from Broad Portfolio and Pipeline at AACR Annual Meeting 2024
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-19.26%
|
O:
0.54%
H:
0.46%
C:
-1.09%
pipeline
preclinical
meeting
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
Published:
2024-03-05
(Crawled : 22:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-26.13%
|
O:
1.0%
H:
3.14%
C:
1.07%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-19.26%
|
O:
0.54%
H:
0.46%
C:
-1.09%
association
cancer
research
preclinical
meeting
BeiGene Announces New Efficacy Analysis Comparing BRUKINSA® vs Acalabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
Published:
2024-02-29
(Crawled : 16:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.43%
|
O:
-1.36%
H:
0.0%
C:
-5.91%
brukinsa
leukemia
BeiGene to Present at Upcoming Investor Conferences - February 28, 2024
Published:
2024-02-28
(Crawled : 14:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.92%
|
O:
-3.44%
H:
3.23%
C:
2.86%
BeiGene’s Biologics License Application for TEVIMBRA® (tislelizumab) for First-Line Gastric or Gastroesophageal Junction Cancers Accepted by FDA
Published:
2024-02-27
(Crawled : 12:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-19.18%
|
O:
2.93%
H:
9.05%
C:
8.94%
tevimbra
fda
license
application
Zymeworks Announces Participation in Upcoming March 2024 Investor Conferences
Published:
2024-02-27
(Crawled : 12:00)
- biospace.com/
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-28.46%
|
O:
1.21%
H:
4.95%
C:
3.04%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-19.18%
|
O:
2.93%
H:
9.05%
C:
8.94%
Zymeworks Announces Participation in Upcoming Investor Conferences
Published:
2024-02-27
(Crawled : 11:00)
- globenewswire.com
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
-28.46%
|
O:
1.21%
H:
4.95%
C:
3.04%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-19.18%
|
O:
2.93%
H:
9.05%
C:
8.94%
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
Published:
2024-02-26
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-16.49%
|
O:
2.6%
H:
1.87%
C:
0.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.0%
|
O:
-0.31%
H:
0.55%
C:
-0.66%
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published:
2024-02-26
(Crawled : 12:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-24.89%
|
O:
-0.29%
H:
7.38%
C:
6.02%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-16.49%
|
O:
2.6%
H:
1.87%
C:
0.7%
business
year
financial
results
BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published:
2024-02-26
(Crawled : 11:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-16.49%
|
O:
2.6%
H:
1.87%
C:
0.7%
lung
chmp
positive
cancer
cell
treatment
← Previous
1
2
3
4
5
6
7
8
9
…
16
17
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.